Regulation of chemokine expression in atherosclerosis

Vascular Pharmacology

Volumn 38, Issue 5, 2002, Pages 283-292

  Burke Gaffney, Anne ^a   Brooks, Alison V S ^a   Bogle, Richard G ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adhesion; Cell cell interaction; Chemokines; Endothelial cell; Leukocytes

Indexed keywords

ALPHA CHEMOKINE; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; CHEMOKINE; CHOLESTEROL; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ENALAPRIL; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN J2; RANTES; TROGLITAZONE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LEUKOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RISK FACTOR; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIOSCLEROSIS; CELL COMMUNICATION; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CHEMOKINE;

EID: 0036590638     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00253-7     Document Type: Article

References (97)

1. Abi-Younes S., Sauty A., Mach F., Sukhova G.K., Libby P., Luster A.D. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ. Res. 86:2000;131-138.
2. Boisvert W.A., Santiago R., Curtiss L.K., Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101:1998;353-363.
3. Boisvert W.A., Curtiss L.K., Terkeltaub R.A. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol. Res. 21:2000;129-137.
4. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
5. Brooks A.V.S., Burke-Gaffney A. Differential effects of chemokine release during neutrophil-endothelial cells interactions. Am. J. Respir. Crit. Care Med. 163:2001;A593.
6. Brooks A., Blease K., Hellewell P., Burke-Gaffney A. Production of chemokines during neutrophil-endothelial interactions. Thorax. 55:2000;A1.
7. Burke-Gaffney A., Griffiths M. Adhesion molecules in acute lung injury. Evans T.W., Griffiths M.J.D., Keogh B. European Respiratory Monographs: ARDS. 2001;International Publishers, Copenhagen. in press.
8. Burke-Gaffney A., Hellewell P. Contribution of endothelial cells to airways inflammation. Page P., Banner C., Spina D. Cellular Mechanisms in Airway Inflammation. 2000;223-244 Birkhauser Verlag, Basel.
9. Bustos C., Hernandez-Presa M.A., Ortego M., Tunon J., Ortega L., Perez F., Diaz C., Hernandez G., Egido J. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J. Am. Coll. Cardiol. 32:1998;2057-2064.
10. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
11. Chen W., Knapp W., Majdic O., Stockinger H., Bohmig G.A., Zlabinger G.J. Co-ligation of CD31 and Fc gamma RII induces cytokine production in human monocytes. J. Immunol. 152:1994;3991-3997.
12. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ. Res. 83:1998;952-959.
13. Chinetti G., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflammation Res. 49:2000;497-505.
14. Claise C., Edeas M., Chalas J., Cockx A., Abella A., Capel L., Lindenbaum A. Oxidized low-density lipoprotein induces the production of interleukin-8 by endothelial cells. FEBS Lett. 398:1996;223-227.
15. Corsini A., Bernini F., Quarato P., Donetti E., Bellosta S., Fumagalli R., Paoletti R., Soma V.M. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Cardiology. 87:1996;458-468.
16. Corsini A., Bellosta S., Baetta R., Fumagalli R., Paoletti R., Bernini F. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol. Ther. 84:1999;413-428.
17. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 143:1999;205-211.
18. De Castellarnau C., Sanchez-Quesada J.L., Benitez S., Rosa R., Caveda L., Vila L., Ordonez-Llanos J. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells. Arterioscler., Thromb., Vasc. Biol. 20:2000;2281-2287.
19. Doerschuk C.M., Mizgerd J.P., Kubo H., Qin L., Kumasaka T. Adhesion molecules and cellular biomechanical changes in acute lung injury: Giles F. Filley lecture. Chest. 116:1999;37S-43S.
20. Dunky A., Neumuller J., Menzel J. Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells. Clin. Immunol. Immunopathol. 85:1997;297-314.
21. Ericsson C.G., Hamsten A., Nilsson J., Grip L., Svane B., de Faire U. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet. 347:1996;849-853.
22. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4312-4317.
23. Frick M.H., Syvanne M., Nieminen M.S., Kauma H., Majahalme S., Virtanen V., Kesaniemi Y.A., Pasternack A., Taskinen M.R. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation. 96:1997;2137-2143.
24. Gerard C., Rollins B.J. Chemokines and disease. Nat. Immunol. 2:2001;108-115.
25. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone M.A. Jr., Luster A.D., Luscinskas F.W., Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 398:1999;718-723.
26. Gimbrone M.A. Jr., Nagel T., Topper J.N. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J. Clin. Invest. 100:1997;S61-S65.
27. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., Rollins B.J., Charo I.F. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103:1999;773-778.
28. Grip O., Janciauskiene S., Lindgren S. Pravastatin down-regulates inflammatory mediators in human monocytes in vitro. Eur. J. Pharmacol. 410:2000;83-92.
29. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:1998;275-281.
30. Haley K.J., Lilly C.M., Yang J.H., Feng Y., Kennedy S.P., Turi T.G., Thompson J.F., Sukhova G.H., Libby P., Lee R.T. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation. 102:2000;2185-2189.
31. Han K.H., Quehenberger O. Ligands for peroxisome proliferator-activated receptor inhibit monocyte CCR2 expression stimulated by plasma lipoproteins. Trends Cardiovasc. Med. 10:2000;209-216.
32. Han K.H., Tangirala R.K., Green S.R., Quehenberger O. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler., Thromb., Vasc. Biol. 18:1998;1983-1991.
33. Han K.H., Han K.O., Green S.R., Quehenberger O. Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J. Lipid Res. 40:1999;1053-1063.
34. Han K.H., Chang M.K., Boullier A., Green S.R., Li A., Glass C.K., Quehenberger O. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J. Clin. Invest. 106:2000;793-802.
35. Hayes I.M., Jordan N.J., Towers S., Smith G., Paterson J.R., Earnshaw J.J., Roach A.G., Westwick J., Williams R.J. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler., Thromb., Vasc. Biol. 18:1998;397-403.
36. Heinel L.A., Singleton D., Miller M., Frewin M.B., Gudewicz P.W. Monocyte adherence to the subendothelial basement membrane increases interleukin-8 gene expression and antigen release. Inflammation. 19:1995;517-527.
37. Hisada Y., Sakurai H., Sugaya T. Cell to cell interaction between mesangial cells and macrophages induces the expression of monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Biochem. Biophys. Res. Commun. 269:2000;309-316.
38. Holmes M., Zhang P., Nelson S., Summer W., Bagby G. Neutrophils alter the pulmonary cytokine response to intratracheal LPS. Am. J. Respir. Crit. Care Med. 163:2001;A948.
39. Huo Y., Hafezi-Moghadam A., Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res. 87:2000;153-159.
40. Jackson S.M., Parhami F., Xi X.P., Berliner J.A., Hsueh W.A., Law R.E., Demer L.L. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler., Thromb., Vasc. Biol. 19:1999;2094-2104.
41. Kasahara K., Strieter R.M., Chensue S.W., Standiford T.J., Kunkel S.L. Mononuclear cell adherence induces neutrophil chemotactic factor/interleukin-8 gene expression. J. Leukocyte Biol. 50:1991;287-295.
42. Kasahara K., Strieter R.M., Standiford T.J., Kunkel S.L. Adherence in combination with lipopolysaccharide, tumor necrosis factor or interleukin-1 beta potentiates the induction of monocyte-derived interleukin-8. Pathobiology. 61:1993;57-66.
43. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 258:1992;1798-1801.
44. Kothe H., Dalhoff K., Rupp J., Muller A., Kreuzer J., Maass M., Katus H.A. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation. 101:2000;1760-1763.
45. Kowala M.C., Recce R., Beyer S., Gu C., Valentine M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis. 149:2000;323-330.
46. Kubes P., Kerfoot S.M. Leukocyte recruitment in the microcirculation: the rolling paradigm revisited. News Physiol. Sci. 16:2001;76-80.
47. Kuroiwa T., Lee E.G., Danning C.L., Illei G.G., McInnes I.B., Boumpas D.T. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms. J. Immunol. 163:1999;2168-2175.
48. Kuroiwa T., Schlimgen R., Illei G.G., McInnes I.B., Boumpas D.T. Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonephritides. J. Immunol. 164:2000;3323-3329.
49. Law R.E., Meehan W.P., Xi X.P., Graf K., Wuthrich D.A., Coats W., Faxon D., Hsueh W.A. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1996;1897-1905.
50. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., Hama S., Borromeo C., Evans R.M., Berliner J.A., Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 87:2000;516-521.
51. Lee S.C., Brummet M.E., Shahabuddin S., Woodworth T.G., Georas S.N., Leiferman K.M., Gilman S.C., Stellato C., Gladue R.P., Schleimer R.P., Beck L.A. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J. Immunol. 164:2000;3392-3401.
52. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270:1995;12953-12956.
53. Ley K., Huo Y. VCAM-1 is critical in atherosclerosis. J. Clin. Invest. 107:2001;1209-1210.
54. Liao F., Berliner J.A., Mehrabian M., Navab M., Demer L.L., Lusis A.J., Fogelman A.M. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87:1991;2253-2257.
55. Lukacs N.W., Strieter R.M., Elner V.M., Evanoff H.L., Burdick M., Kunkel S.L. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood. 83:1994;1174-1178.
56. Lukacs N.W., Strieter R.M., Elner V., Evanoff H.L., Burdick M.D., Kunkel S.L. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood. 86:1995;2767-2773.
57. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445.
58. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., Luster A.D. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 104:1999;1041-1050.
59. Mackay C.R. Chemokines: immunology's high impact factors. Nat. Immunol. 2:2001;95-101.
60. Marx N., Sukhova G.K., Collins T., Libby P., Plutzky J. PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 99:1999;3125-3131.
61. Marx N., Mach F., Sauty A., Leung J.H., Sarafi M.N., Ransohoff R.M., Libby P., Plutzky J., Luster A.D. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164:2000;6503-6508.
62. 3CR1 as a genetic risk factor for coronary artery disease. Blood. 97:2001;1925-1928.
63. Murao K., Imachi H., Momoi A., Sayo Y., Hosokawa H., Sato M., Ishida T., Takahara J. Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells. FEBS Lett. 454:1999;27-30.
64. Murdoch C., Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 95:2000;3032-3043.
65. Nelken N.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1991;1121-1127.
66. Ramos C.L., Huo Y., Jung U., Ghosh S., Manka D.R., Sarembock I.J., Ley K. Direct demonstration of P-selectin-and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ. Res. 84:1999;1237-1244.
67. Rayner K., Van Eersel S., Groot P.H., Reape T.J. Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse. J. Vasc. Res. 37:2000;93-102.
68. Reape T.J., Rayner K., Manning C.D., Gee A.N., Barnette M.S., Burnand K.G., Groot P.H. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am. J. Pathol. 154:1999;365-374.
69. Resnick N., Gimbrone M.A. Jr. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 9:1995;874-882.
70. Romano M., Diomede L., Sironi M., Massimiliano L., Sottocorno M., Polentarutti N., Guglielmotti A., Albani D., Bruno A., Fruscella P., Salmona M., Vecchi A., Pinza M., Mantovani A. Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab. Invest. 80:2000;1095-1100.
71. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
72. Saitoh K., Mori T., Kasai H., Nagayama T., Tsuchiya A., Ohbayashi S. Anti-atheromatous effects of fenofibrate, a hypolipidemic drug: I. Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits. Nippon Yakurigaku Zasshi. 106:1995;41-50.
73. Salcedo R., Resau J.H., Halverson D., Hudson E.A., Dambach M., Powell D., Wasserman K., Oppenheim J.J. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14:2000;2055-2064.
74. Salcedo R., Young H.A., Ponce M.L., Ward J.M., Kleinman H.K., Murphy W.J., Oppenheim J.J. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3(+) endothelial cells. J. Immunol. 166:2001;7571-7578.
75. Sano H., Nakagawa N., Chiba R., Kurasawa K., Saito Y., Iwamoto I. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 250:1998;694-698.
76. Schecter A.D., Calderon T.M., Berman A.B., McManus C.M., Fallon J.T., Rossikhina M., Zhao W., Christ G., Berman J.W., Taubman M.B. Human vascular smooth muscle cells possess functional CCR5. J. Biol. Chem. 275:2000;5466-5471.
77. Schratzberger P., Dunzendorfer S., Reinisch N., Kahler C.M., Herold M., Wiedermann C.J. Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils. Cardiovasc. Res. 38:1998;516-521.
78. Shi W., Haberland M.E., Jien M.L., Shih D.M., Lusis A.J. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 102:2000;75-81.
79. Simonini A., Moscucci M., Muller D.W., Bates E.R., Pagani F.D., Burdick M.D., Strieter R.M. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation. 101:2000;1519-1526.
80. Soejima H., Ogawa H., Yasue H., Kaikita K., Takazoe K., Nishiyama K., Misumi K., Miyamoto S., Yoshimura M., Kugiyama K., Nakamura S., Tsuji I. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J. Am. Coll. Cardiol. 34:1999;983-988.
81. Sporri B., Bickel M., Limat A., Waelti E.R., Hunziker T., Wiesmann U.N. Juxtacrine stimulation of cytokine production in cocultures of human dermal fibroblasts and T cells. Cytokine. 8:1996;631-635.
82. Stary H.C., Chandler A.B., Glagov S., Guyton J.R., Insull W. Jr., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W.D., Wissler R.W. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 89:1994;2462-2478.
83. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriott D., Chan S-Y., Roczniak S., Shanafelt A.B. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:1995;27348-27357.
84. Takahashi M., Masuyama J., Ikeda U., Kasahara T., Kitagawa S., Takahashi Y., Shimada K., Kano S. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro. Circ. Res. 76:1995;750-757.
85. Takahashi M., Masuyama J., Ikeda U., Kitagawa S., Kasahara T., Saito M., Kano S., Shimada K. Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration in vitro. Arterioscler., Thromb., Vasc. Biol. 15:1995;629-636.
86. Takeya M., Yoshimura T., Leonard E.J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 24:1993;534-539.
87. Terada N., Maesako K., Hamano N., Houki G., Ikeda T., Sai M., Yamashita T., Fukuda S., Wakita A., Yoshimura K., Konno A. Eosinophil adhesion regulates RANTES production in nasal epithelial cells. J. Immunol. 158:1997;5464-5470.
88. Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than just lower cholesterol. Lancet. 348:1996;1079-1082.
89. Wang N., Tabas I., Winchester R., Ravalli S., Rabbani L.E., Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J. Biol. Chem. 271:1996;8837-8842.
90. Weber C., Draude G., Weber K.S., Wubert J., Lorenz R.L., Weber P.C. Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions. Atherosclerosis. 145:1999;115-123.
91. Weber K.S., Nelson P.J., Grone H.J., Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler., Thromb., Vasc. Biol. 19:1999;2085-2093.
92. Welsh D., Zhang P., Mason C., Bagby G., Summer W., Nelson S. Circulating PMN modulate LPS-induced CINC production by alveolar epithelial cells. Am. J. Respir. Crit. Care Med. 163:2001;A593.
93. Woenckhaus C., Kaufmann A., Bussfeld D., Gemsa D., Sprenger H., Grone H.J. Hypochlorite-modified LDL: chemotactic potential and chemokine induction in human monocytes. Clin. Immunol. Immunopathol. 86:1998;27-33.
94. Wu D., Koga T., Martin K.R., Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis. 147:1999;297-307.
95. Xu L., Kelvin D.J., Ye G.Q., Taub D.D., Ben-Baruch A., Oppenheim J.J., Wang J.M. Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL-8. J. Leukocyte Biol. 57:1995;335-342.
96. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 88:1991;5252-5256.
97. Yue T.L., Wang X., Sung C.P., Olson B., McKenna P.J., Gu J.L., Feuerstein G.Z. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ. Res. 75:1994;1-7.